To further untangle the chemotherapy-induced procoagulant response in GBM cell lines, we performed another FXa generation assay in the presence of the TF antagonistic antibody 5G9 (which inhibits TF-mediated coagulation), PS-binding Annexin V or TIB115 as IgG1 control (Figure 4). The gene discussed is ANXA5; the disease is glioblastoma.